potassium deficiency disease
potassium deficiency disease
Explore linked clinical trials. Standard reference: MONDO:00030197 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) | Abnormalities, Multiple, Arrhythmias, Cardiac, COVID-19, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Coronaviridae Infections, Down syndrome, Dyssomnias, Edema, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Hemic and Lymphatic Diseases, Hemorrhage, Infant, Newborn, Diseases, Infant, Premature, Diseases, Infections, Inflammation, Kawasaki disease, Lung Injury, Menorrhagia, Menstruation Disturbances, Neurobehavioral Manifestations, Neurologic Manifestations, Nidovirales infectious disease, Nutritional and Metabolic Diseases, Orthocoronavirinae infectious disease, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Signs and Symptoms, Skin and Connective Tissue Diseases, Sleep Disorders, Intrinsic, Suppuration, Urogenital Diseases, Uterine Hemorrhage, Ventilator-Induced Lung Injury, Water-Electrolyte Imbalance, adrenal gland disorder, adrenal gland hyperfunction, adrenocortical insufficiency, attention deficit hyperactivity disorder, inattentive type, blood coagulation disease, bronchopulmonary dysplasia, cardiovascular disorder, cellulitis, chromosomal disorder, coagulation protein disease, connective tissue disorder, endocrine system disorder, female reproductive system disorder, heart disorder, heart failure, hematologic disorder, hemophilia A, hemorrhagic disease, hereditary disease, hyperaldosteronism, hyperphosphatemia, hypertensive disorder, inherited blood coagulation disorder, insomnia, intellectual disability, lung disorder, lymphatic system disorder, metabolic disease, nervous system disorder, neurodevelopmental disorder, oppositional defiant disorder, pediatric multisystem inflammatory disease, COVID-19 related, phosphorus metabolism disease, pneumonia, potassium deficiency disease, primary aldosteronism, psychiatric disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder, respiratory tract infectious disorder, skin disorder, skin disorder caused by infection, skin infection, skin vascular disease, sleep-wake disorder, uterine disorder, vascular disorder, vascular hemostatic disease, vasculitis, viral infectious disease, viral pneumonia | Recruiting | Not stated | 2026-08-21 | NCT04278404 | |
| Potassium Supplementation in CKD | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hyperkalemia, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Water-Electrolyte Imbalance, cardiovascular disorder, chronic renal failure syndrome, hypertensive disorder, kidney disorder, kidney failure, metabolic disease, potassium deficiency disease, urinary system disorder, vascular disorder | Active, not recruiting | Not applicable | 2026-08-10 | NCT03253172 | |
| Radiofrequency Ablation Versus Adrenalectomy for Adenoma in Patients With Primary Aldosteronism and Hypertension | Neoplasms by Site, Nutritional and Metabolic Diseases, Water-Electrolyte Imbalance, adrenal cortex adenoma, adrenal cortex disorder, adrenal cortex neoplasm, adrenal gland cancer, adrenal gland disorder, adrenal gland hyperfunction, cardiovascular disorder, endocrine system disorder, hyperaldosteronism, hypertensive disorder, malignant endocrine neoplasm, metabolic disease, neoplasm, potassium deficiency disease, vascular disorder | Recruiting | Not applicable | 2026-06-11 | NCT07470580 | |
| Combination Osilodrostat and Cabergoline in Cushing's Disease | 46,XX disorder of sex development, ACTH-dependent Cushing syndrome, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hyperandrogenism, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Urogenital Abnormalities, Urogenital Diseases, Water-Electrolyte Imbalance, adrenal gland disorder, adrenocortical insufficiency, adrenogenital syndrome, brain disorder, cardiovascular disorder, central nervous system disorder, disorder of sexual differentiation, endocrine system disorder, gonadal disorder, hyperpituitarism, hypertensive disorder, hypothalamic disorder, metabolic disease, nervous system disorder, pituitary gland disorder, potassium deficiency disease, vascular disorder | Enrolling by invitation | Phase 4 | 2026-05-22 | NCT07603466 | |
| Tissue Sodium Quantification in Patients With Primary Aldosteronism: See Sodium to Treat | Nutritional and Metabolic Diseases, Water-Electrolyte Imbalance, adrenal gland disorder, adrenal gland hyperfunction, cardiovascular disorder, endocrine system disorder, hyperaldosteronism, hypertensive disorder, metabolic disease, potassium deficiency disease, primary aldosteronism, vascular disorder | Recruiting | Not stated | 2025-06-06 | NCT06569589 | |
| Targeted Potassium Levels for Prevention of ICD Therapy | Arrhythmias, Cardiac, Cardiac Conduction System Disease, Hyperkalemia, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tachycardia, Water-Electrolyte Imbalance, atrial fibrillation, cardiac arrest, cardiovascular disorder, heart disorder, metabolic disease, potassium deficiency disease, ventricular tachycardia | Active, not recruiting | Phase 4 | 2025-05-09 | NCT03833089 | |
| the Cardioprotective Effects of Improving Potassium Variability in Maintenance Hemodialysis Patients | Hyperkalemia, Nutritional and Metabolic Diseases, Water-Electrolyte Imbalance, metabolic disease, potassium deficiency disease | Not yet recruiting | Phase 4 | 2024-12-16 | NCT06736184 |